Experts from different countries gathered at the international Lancet Neurology Autoimmune Disorder Conference on 26th and 27th March in Barcelona to discuss the latest findings in research on neuronal autoimmunity and target antigens in CNS. EUROIMMUN was one of the major sponsors of the conference. N-methyl-D-aspartate receptor (NMDAR), an important molecule for the synaptic impulse […]
On 22nd March the 12th “International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders” (AD/PD™ 2015) closed in Nice, (France). Scientists from all over the world discussed causes and treatment of Alzheimer’s dementia and Parkinson’s disease. New knowledge is urgently needed in this area of Research. Neurodegenerative diseases, in particular Alzheimer’s, are today
The 40. Arab Health conference took place in Dubai from January 26th – 29th. It is considered as largest health care event in the Middle East and as second largest trade fair in the world. 4.000 exhibitors coming from 40 nations presented their innovations in the fields of e.g. diagnostics, laboratory equipment, imaging and information systems in the International Convention and Exhibition Center. More than 120.000 attendees and visitors were
EUROIMMUN US exhibited at the American Society of Nephrology (ASN) Kidney Week 2014, the premier international nephrology meeting, in Philadelphia November 11th-16th. More than 13,000 professionals participated and the EUROIMMUN attendees reported on valuable feedback regarding anti-PLA2R antibodies, the new biomarker of primary membranous nephropathy. “ASN went very well”, concluded Todd Walbrun, the National Accounts
The MEDICA is considered as leading international medical trade fair for suppliers’ products in medical manufacture. EUROIMMUN presented again with a large booth together with 4,830 other exhibitors in 2014. The conclusion of the organizers is positive: they expect that the 130,000 visitors from about 120 different countries will generate tailwinds for the future export business. And what will
